Skip to main content

Advertisement

SpringerLink
Log in

Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis

  • Case Report
  • Published:
Modern Rheumatology

Abstract

We report the case of a 44-year-old female undergoing maintenance hemodialysis in whom early-phase rheumatoid arthritis (RA) was successfully treated by leukocytapheresis (LCAP). The effects of prednisone, tacrolimus, and etanercept were limited, but LCAP was highly effective and its efficacy continued even after cessation of LCAP. Moreover, remission was maintained for 2 years after discontinuation of medication. LCAP may be an important treatment option for RA patients with end-stage renal failure who are on hemodialysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Izumi Y, Tominaga M, Iwanaga N, Huang M, Tanaka F, Aratake K, et al. Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis. Mod Rheumatol. 2006;16:20–3.

    Article  PubMed  Google Scholar 

  2. Ueki Y, Sagawa A, Tanimura K, Yamada A, Yamamoto K, Tsuda H, et al. A multicenter study of leukocytapheresis in rheumatoid arthritis. Clin Exp Rheumatol. 2007;25:810–6.

    PubMed  CAS  Google Scholar 

  3. Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Kataharada K, Ishizuka T, et al. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 1999;42:431–7.

    Article  PubMed  CAS  Google Scholar 

  4. Ohsawa I, Ohi H, Maruyama T, Hamada H, Tomino Y. Leukocytapheresis (LCAP) for the treatment of rheumatoid arthritis on a maintenance hemodialysis patient. Clin Nephrol. 2007;68:121–4.

    PubMed  CAS  Google Scholar 

  5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.

    Article  PubMed  CAS  Google Scholar 

  6. Basile C, Montanaro A, Semeraro A. Should low-dose methotrexate therapy be prescribed to dialysis patients? Nephrol Dial Transpl. 2002;17:530–1.

    Article  Google Scholar 

  7. Yamashita M, Natsumeda M, Takasugi K, Ueno A, Ezawa K. Efficacy and safety of tacrolimus treatment for rheumatoid arthritis patients undergoing hemodialysis. Mod Rheumatol. 2008;18:296–300.

    Article  PubMed  CAS  Google Scholar 

  8. Singh R, Cuchacovich R, Huang W, Espinoza LR. Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol. 2002;29:636–7.

    PubMed  Google Scholar 

  9. Hammoudeh M. Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis. Rheumatology (Oxford). 2006;45:357–9.

    Article  CAS  Google Scholar 

  10. Sugioka Y, Inui K, Koike T. Use of etanercept in a patient with rheumatoid arthritis on hemodialysis. Mod Rheumatol. 2008;18:293–5.

    Article  PubMed  Google Scholar 

  11. Nakamura T, Higashi S, Tomoda K, Tsukano M, Arizono K. Etanercept treatment in patients with rheumatoid arthritis on dialysis. Rheumatol Int. 2010;30:1527–8.

    Article  PubMed  Google Scholar 

  12. Iwamoto M, Honma S, Asano Y, Minota S. Effective and safe administration of tocilizumab to a patient with rheumatoid arthritis on haemodialysis. Rheumatol Int. 2011;31:559–60.

    Article  PubMed  Google Scholar 

  13. Yoshihara R, Ooyama M, Nakao K, Fujimori A. Pulmonary nocardiosis in a hemodialysis patient with rheumatoid arthritis receiving etanercept. J Jpn Soc Dail Ther. 2010;43:341–6.

    Article  Google Scholar 

  14. Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, et al. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher. 1999;3:178–85.

    Article  PubMed  CAS  Google Scholar 

  15. Hidaka T, Suzuki K, Kawakami M, Okada M, Kataharada K, Shinohara T, et al. Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. J Clin Apher. 2001;16:74–81.

    Article  PubMed  CAS  Google Scholar 

  16. Yamaji K, Yang K, Tsuda H, Hashimoto H. Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers. Ther Apher. 2002;6:402–12.

    Article  PubMed  Google Scholar 

  17. Hidaka T. The mechanism of the efficiency of leukocytapheresis on rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi. 2011;34:447–55.

    Article  PubMed  Google Scholar 

  18. Umekita K, Hidaka T, Ueno S, Takajo I, Kai Y, Nagatomo Y, et al. Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritis. Mod Rheumatol. 2009;19:265–72.

    Article  PubMed  Google Scholar 

  19. Sakai Y, Sakai S, Otsuka T, Ohno D, Murasawa T, Munakata K, et al. Efficacy of high-throughput leukocytapheresis for rheumatoid arthritis with a reduced response to infliximab. Ther Apher Dial. 2009;13:179–85.

    Article  PubMed  Google Scholar 

  20. Hayashi W, Nishikawa Y, Tominaga T, Takashima H, Terada H, Ueki Y, et al. A case of eosinophilia caused by nafamostat mesilate following leukocytapheresis in a rheumatoid arthritis patient undergoing hemodialysis. Kyushu J Rheumatol. 2006;26:36–40.

    Google Scholar 

  21. Nagase K, Fukunaga K, Ohnishi K, Kusaka T, Matoba Y, Sawada K. Detection of specific IgE antibodies to nafamostat mesilate as an indication of possible adverse effects of leukocytapheresis using nafamostat mesilate as anticoagulant. Ther Apher Dial. 2004;8:45–51.

    Article  PubMed  CAS  Google Scholar 

  22. Sato T, Imamura N, Nozaki K, Ishigaki Y. Treatment of multiple sclerosis with lymphocytapheresis using a leukocyte adsorption column. Nihon Rinsho. 1994;52:3032–7.

    PubMed  CAS  Google Scholar 

  23. Onuma S, Yamaji K, Kempe K, Ogasawara M, Ogawa T, Yang K, et al. Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis. Ther Apher Dial. 2006;10:404–11.

    Article  PubMed  Google Scholar 

  24. van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum. 2009;60:2262–71.

    Article  PubMed  Google Scholar 

  25. Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 2000;43:22–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine I, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan

    Keisuke Maeshima, Masataka Torigoe, Mikako Iwakura & Koji Ishii

  2. Department of Internal Medicine, Nakatsu Daiichi Hospital, Oita, Japan

    Kunitoshi Yamanaka

Authors
  1. Keisuke Maeshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masataka Torigoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mikako Iwakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kunitoshi Yamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Koji Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koji Ishii.

About this article

Cite this article

Maeshima, K., Torigoe, M., Iwakura, M. et al. Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis. Mod Rheumatol (2013). https://doi.org/10.1007/s10165-013-0869-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10165-013-0869-0

Keywords

Search

Navigation